List of Tables
Table 1. Global Minimal Residual Disease Testing Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Flow Cytometry
Table 3. Key Players of Polymerase Chain Reaction
Table 4. Global Minimal Residual Disease Testing Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Minimal Residual Disease Testing Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Minimal Residual Disease Testing Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Minimal Residual Disease Testing Market Share by Region (2020-2025)
Table 8. Global Minimal Residual Disease Testing Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Minimal Residual Disease Testing Market Share by Region (2026-2031)
Table 10. Minimal Residual Disease Testing Market Trends
Table 11. Minimal Residual Disease Testing Market Drivers
Table 12. Minimal Residual Disease Testing Market Challenges
Table 13. Minimal Residual Disease Testing Market Restraints
Table 14. Global Minimal Residual Disease Testing Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Minimal Residual Disease Testing Market Share by Players (2020-2025)
Table 16. Global Top Minimal Residual Disease Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Minimal Residual Disease Testing as of 2024)
Table 17. Ranking of Global Top Minimal Residual Disease Testing Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Minimal Residual Disease Testing Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Minimal Residual Disease Testing, Headquarters and Area Served
Table 20. Global Key Players of Minimal Residual Disease Testing, Product and Application
Table 21. Global Key Players of Minimal Residual Disease Testing, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Minimal Residual Disease Testing Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Minimal Residual Disease Testing Revenue Market Share by Type (2020-2025)
Table 25. Global Minimal Residual Disease Testing Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Minimal Residual Disease Testing Revenue Market Share by Type (2026-2031)
Table 27. Global Minimal Residual Disease Testing Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Minimal Residual Disease Testing Revenue Market Share by Application (2020-2025)
Table 29. Global Minimal Residual Disease Testing Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Minimal Residual Disease Testing Revenue Market Share by Application (2026-2031)
Table 31. North America Minimal Residual Disease Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Minimal Residual Disease Testing Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Minimal Residual Disease Testing Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Minimal Residual Disease Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Minimal Residual Disease Testing Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Minimal Residual Disease Testing Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Minimal Residual Disease Testing Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Minimal Residual Disease Testing Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Minimal Residual Disease Testing Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Minimal Residual Disease Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Minimal Residual Disease Testing Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Minimal Residual Disease Testing Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Minimal Residual Disease Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Minimal Residual Disease Testing Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Minimal Residual Disease Testing Market Size by Country (2026-2031) & (US$ Million)
Table 46. Adaptive Biotechnologies Company Details
Table 47. Adaptive Biotechnologies Business Overview
Table 48. Adaptive Biotechnologies Minimal Residual Disease Testing Product
Table 49. Adaptive Biotechnologies Revenue in Minimal Residual Disease Testing Business (2020-2025) & (US$ Million)
Table 50. Adaptive Biotechnologies Recent Development
Table 51. ArcherDX Company Details
Table 52. ArcherDX Business Overview
Table 53. ArcherDX Minimal Residual Disease Testing Product
Table 54. ArcherDX Revenue in Minimal Residual Disease Testing Business (2020-2025) & (US$ Million)
Table 55. ArcherDX Recent Development
Table 56. ARUP Laboratories Company Details
Table 57. ARUP Laboratories Business Overview
Table 58. ARUP Laboratories Minimal Residual Disease Testing Product
Table 59. ARUP Laboratories Revenue in Minimal Residual Disease Testing Business (2020-2025) & (US$ Million)
Table 60. ARUP Laboratories Recent Development
Table 61. Asuragen Company Details
Table 62. Asuragen Business Overview
Table 63. Asuragen Minimal Residual Disease Testing Product
Table 64. Asuragen Revenue in Minimal Residual Disease Testing Business (2020-2025) & (US$ Million)
Table 65. Asuragen Recent Development
Table 66. F. Hoffmann-La Roche Company Details
Table 67. F. Hoffmann-La Roche Business Overview
Table 68. F. Hoffmann-La Roche Minimal Residual Disease Testing Product
Table 69. F. Hoffmann-La Roche Revenue in Minimal Residual Disease Testing Business (2020-2025) & (US$ Million)
Table 70. F. Hoffmann-La Roche Recent Development
Table 71. Guardant Health Company Details
Table 72. Guardant Health Business Overview
Table 73. Guardant Health Minimal Residual Disease Testing Product
Table 74. Guardant Health Revenue in Minimal Residual Disease Testing Business (2020-2025) & (US$ Million)
Table 75. Guardant Health Recent Development
Table 76. Labcorp Company Details
Table 77. Labcorp Business Overview
Table 78. Labcorp Minimal Residual Disease Testing Product
Table 79. Labcorp Revenue in Minimal Residual Disease Testing Business (2020-2025) & (US$ Million)
Table 80. Labcorp Recent Development
Table 81. NeoGenomics Laboratories Company Details
Table 82. NeoGenomics Laboratories Business Overview
Table 83. NeoGenomics Laboratories Minimal Residual Disease Testing Product
Table 84. NeoGenomics Laboratories Revenue in Minimal Residual Disease Testing Business (2020-2025) & (US$ Million)
Table 85. NeoGenomics Laboratories Recent Development
Table 86. Sysmex Corporation Company Details
Table 87. Sysmex Corporation Business Overview
Table 88. Sysmex Corporation Minimal Residual Disease Testing Product
Table 89. Sysmex Corporation Revenue in Minimal Residual Disease Testing Business (2020-2025) & (US$ Million)
Table 90. Sysmex Corporation Recent Development
Table 91. Research Programs/Design for This Report
Table 92. Key Data Information from Secondary Sources
Table 93. Key Data Information from Primary Sources
Table 94. Authors List of This Report
List of Figures
Figure 1. Minimal Residual Disease Testing Picture
Figure 2. Global Minimal Residual Disease Testing Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Minimal Residual Disease Testing Market Share by Type: 2024 VS 2031
Figure 4. Flow Cytometry Features
Figure 5. Polymerase Chain Reaction Features
Figure 6. Global Minimal Residual Disease Testing Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Minimal Residual Disease Testing Market Share by Application: 2024 VS 2031
Figure 8. Hospitals and Specialty Clinics Case Studies
Figure 9. Diagnostic Laboratories Case Studies
Figure 10. Academic and Research Institutes Case Studies
Figure 11. Others Case Studies
Figure 12. Minimal Residual Disease Testing Report Years Considered
Figure 13. Global Minimal Residual Disease Testing Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 14. Global Minimal Residual Disease Testing Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Minimal Residual Disease Testing Market Share by Region: 2024 VS 2031
Figure 16. Global Minimal Residual Disease Testing Market Share by Players in 2024
Figure 17. Global Top Minimal Residual Disease Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Minimal Residual Disease Testing as of 2024)
Figure 18. The Top 10 and 5 Players Market Share by Minimal Residual Disease Testing Revenue in 2024
Figure 19. North America Minimal Residual Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. North America Minimal Residual Disease Testing Market Share by Country (2020-2031)
Figure 21. United States Minimal Residual Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Canada Minimal Residual Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Minimal Residual Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Minimal Residual Disease Testing Market Share by Country (2020-2031)
Figure 25. Germany Minimal Residual Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. France Minimal Residual Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. U.K. Minimal Residual Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Italy Minimal Residual Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Russia Minimal Residual Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Nordic Countries Minimal Residual Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Minimal Residual Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Minimal Residual Disease Testing Market Share by Region (2020-2031)
Figure 33. China Minimal Residual Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Japan Minimal Residual Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. South Korea Minimal Residual Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Southeast Asia Minimal Residual Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. India Minimal Residual Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Australia Minimal Residual Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Minimal Residual Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Minimal Residual Disease Testing Market Share by Country (2020-2031)
Figure 41. Mexico Minimal Residual Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Brazil Minimal Residual Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Minimal Residual Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Minimal Residual Disease Testing Market Share by Country (2020-2031)
Figure 45. Turkey Minimal Residual Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Saudi Arabia Minimal Residual Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. UAE Minimal Residual Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Adaptive Biotechnologies Revenue Growth Rate in Minimal Residual Disease Testing Business (2020-2025)
Figure 49. ArcherDX Revenue Growth Rate in Minimal Residual Disease Testing Business (2020-2025)
Figure 50. ARUP Laboratories Revenue Growth Rate in Minimal Residual Disease Testing Business (2020-2025)
Figure 51. Asuragen Revenue Growth Rate in Minimal Residual Disease Testing Business (2020-2025)
Figure 52. F. Hoffmann-La Roche Revenue Growth Rate in Minimal Residual Disease Testing Business (2020-2025)
Figure 53. Guardant Health Revenue Growth Rate in Minimal Residual Disease Testing Business (2020-2025)
Figure 54. Labcorp Revenue Growth Rate in Minimal Residual Disease Testing Business (2020-2025)
Figure 55. NeoGenomics Laboratories Revenue Growth Rate in Minimal Residual Disease Testing Business (2020-2025)
Figure 56. Sysmex Corporation Revenue Growth Rate in Minimal Residual Disease Testing Business (2020-2025)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed
